Abstract
Diabetic vascular complication is a leading cause of end-stage renal failure, acquired blindness, a variety of neuropathies and accelerated atherosclerosis, which could account for disabilities and high mortality rates in patients with diabetes. There is a growing body of evidence to conclude that intensive control of plasma glucose and blood pressure is crucial for effectively reducing diabetic vascular complication. So far, various molecular mechanisms have been proposed to play a role in the development and progression of diabetic vascular complication. In this paper, we review potential therapeutic strategies for the prevention of diabetic vascular complication, especially focusing on the signal transduction pathways activated under diabetes.
Keywords: Advanced glycation end products, diabetic vascular complication, oxidative stress, enin-angiotensin system
Current Signal Transduction Therapy
Title: Signal Transduction Therapy of Diabetic Vascular Complication
Volume: 2 Issue: 1
Author(s): Sho-ichi Yamagishi, Kazuo Nakamura, Takanori Matsui, Yumiko Yoshida, Katsuhiko Takenaka, Yuko Jinnouchi and Tsutomu Imaizumi
Affiliation:
Keywords: Advanced glycation end products, diabetic vascular complication, oxidative stress, enin-angiotensin system
Abstract: Diabetic vascular complication is a leading cause of end-stage renal failure, acquired blindness, a variety of neuropathies and accelerated atherosclerosis, which could account for disabilities and high mortality rates in patients with diabetes. There is a growing body of evidence to conclude that intensive control of plasma glucose and blood pressure is crucial for effectively reducing diabetic vascular complication. So far, various molecular mechanisms have been proposed to play a role in the development and progression of diabetic vascular complication. In this paper, we review potential therapeutic strategies for the prevention of diabetic vascular complication, especially focusing on the signal transduction pathways activated under diabetes.
Export Options
About this article
Cite this article as:
Yamagishi Sho-ichi, Nakamura Kazuo, Matsui Takanori, Yoshida Yumiko, Takenaka Katsuhiko, Jinnouchi Yuko and Imaizumi Tsutomu, Signal Transduction Therapy of Diabetic Vascular Complication, Current Signal Transduction Therapy 2007; 2 (1) . https://dx.doi.org/10.2174/157436207779317100
DOI https://dx.doi.org/10.2174/157436207779317100 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Developments in Nanoparticle Based Targeted Delivery of Chemotherapeutics
Current Bioactive Compounds Immunomodulatory Activity of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Imidazoline Receptor Agonists in Obesity-Related Hypertension: Therapeutic Targeting of the Sympathetic Nervous System
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Effect of Sex and Gender on Diabetic Complications
Current Diabetes Reviews Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide
Current Drug Metabolism Estrogenic Compounds, Estrogen Receptors and Vascular Cell Signaling in the Aging Blood Vessels
Current Medicinal Chemistry Myocardial Energetics in Left Ventricular Hypertrophy
Current Cardiology Reviews Endothelial Activation. Sliding Door to Atherosclerosis
Current Pharmaceutical Design Adenosine Receptor Ligands-Recent Developments Part I. Agonists
Current Medicinal Chemistry Squalene as Novel Food Factor
Current Pharmaceutical Biotechnology Mechanisms of Endothelial Dysfunction: Clinical Significance and Preventive Non-Pharmacological Therapeutic Strategies
Current Pharmaceutical Design Adipose Tissue as a Regulator of Energy Balance
Current Drug Targets Hyperhomocysteinaemia: A Critical Review of Old and New Aspects
Current Drug Metabolism Role of Adiponectin in Obesity, Hypertension, and Metabolic Syndrome
Current Hypertension Reviews Role of Vascular Endothelial Growth Factor in Kidney Disease
Current Vascular Pharmacology Disparities in Cardiovascular Disease Risk in the United States
Current Cardiology Reviews Physiologic Tailoring of Treatment in Resistant Hypertension
Current Cardiology Reviews The Critical Roles of HSC70 in Physiological and Pathological Processes
Current Pharmaceutical Design Cross Talk Among Leukocytes, Platelets, and Endothelial Cells and its Relevance to Atherosclerosis and Coronary Heart Disease
Current Nutrition & Food Science Therapeutic Potential of High Mobility Group Box-1 in Ischemic Injury and Tissue Regeneration
Current Vascular Pharmacology